Multi-Year Registry Study of Elapegademase-lvlr Treatment in Patients with Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy (ERT)

Document Type

Conference Proceeding

Publication Date

4-23-2024

Publication Title

Clinical Immunology

Abstract

2024 Clinical Immunology Society Annual Meeting: Immune Deficiency and Dysregulation North American Conference, May 1 - 4, 2024, Minneapolis, MN

Volume

262

Issue

Supplement

Comments

Abstract Number 20

This document is currently not available here.

Share

COinS